HIGHLIGHTS
- who: Taobo Hu and colleagues from the Department of Surgery, Peking University People's Hospital, Beijing, China have published the article: Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy, in the Journal: (JOURNAL)
- what: The authors compared the clinicopathological characteristics and survival of 41 TNAC cases with paired TNBC cases, 21 of which had received neoadjuvant therapy.
- how: More significantly the results showed that TNAC patients have a poor chemotherapy responsiveness and no benefit from chemotherapy in terms of BCSS.
- future: A further study with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.